MMP‐13 degrades ECM components, including Ln‐5, continuously promoting endothelial cell migration in the ECM, the release of VEGF and bFGF, and ultimately the generation of endothelium‐dependent vascular tumours. The gene discussed is FGF2; the disease is vascular neoplasm.